Sanz Camila, Zamberlan Federico, Erowid Earth, Erowid Fire, Tagliazucchi Enzo
Departamento de Física, Universidad de Buenos Aires, Buenos Aires, Argentina.
Brain and Spine Institute, Paris, France.
Front Neurosci. 2018 Jan 22;12:7. doi: 10.3389/fnins.2018.00007. eCollection 2018.
Ever since the modern rediscovery of psychedelic substances by Western society, several authors have independently proposed that their effects bear a high resemblance to the dreams and dreamlike experiences occurring naturally during the sleep-wake cycle. Recent studies in humans have provided neurophysiological evidence supporting this hypothesis. However, a rigorous comparative analysis of the phenomenology ("what it feels like" to experience these states) is currently lacking. We investigated the semantic similarity between a large number of subjective reports of psychoactive substances and reports of high/low lucidity dreams, and found that the highest-ranking substance in terms of the similarity to high lucidity dreams was the serotonergic psychedelic lysergic acid diethylamide (LSD), whereas the highest-ranking in terms of the similarity to dreams of low lucidity were plants of the genus, rich in deliriant tropane alkaloids. Conversely, sedatives, stimulants, antipsychotics, and antidepressants comprised most of the lowest-ranking substances. An analysis of the most frequent words in the subjective reports of dreams and hallucinogens revealed that terms associated with perception ("see," "visual," "face," "reality," "color"), emotion ("fear"), setting ("outside," "inside," "street," "front," "behind") and relatives ("mom," "dad," "brother," "parent," "family") were the most prevalent across both experiences. In summary, we applied novel quantitative analyses to a large volume of empirical data to confirm the hypothesis that, among all psychoactive substances, hallucinogen drugs elicit experiences with the highest semantic similarity to those of dreams. Our results and the associated methodological developments open the way to study the comparative phenomenology of different altered states of consciousness and its relationship with non-invasive measurements of brain physiology.
自西方社会重新发现迷幻物质以来,几位作者独立提出,它们的效果与睡眠-觉醒周期中自然出现的梦境和类梦体验高度相似。最近针对人类的研究提供了支持这一假设的神经生理学证据。然而,目前缺乏对现象学(体验这些状态时“感觉如何”)的严格比较分析。我们调查了大量关于精神活性物质的主观报告与清醒度高/低的梦境报告之间的语义相似性,发现就与清醒度高的梦境的相似性而言,排名最高的物质是血清素能迷幻剂麦角酸二乙酰胺(LSD),而就与清醒度低的梦境的相似性而言,排名最高的是富含致幻托烷生物碱的某属植物。相反,镇静剂、兴奋剂、抗精神病药和抗抑郁药大多是排名最低的物质。对梦境和致幻剂主观报告中最常见词汇的分析表明,与感知(“看见”“视觉”“脸”“现实”“颜色”)、情感(“恐惧”)、场景(“外面”“里面”“街道”“前面”“后面”)以及亲属(“妈妈”“爸爸”“兄弟”“父母”“家人”)相关的词汇在这两种体验中最为普遍。总之,我们对大量实证数据应用了新颖的定量分析方法,以证实这一假设:在所有精神活性物质中,致幻药物引发的体验与梦境的语义相似性最高。我们的研究结果及相关方法学进展为研究不同意识改变状态的比较现象学及其与大脑生理学非侵入性测量之间的关系开辟了道路。